ArticleInternational neurourology journal2026
Inflammatory Signatures and Biomarkers: The Renal-Vesical Axis in Alzheimer Progression.
Article in International neurourology journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Alzheimer disease (AD) has long been viewed as a disorder confined to the central nervous system. Accumulating evidence, however, indicates that systemic inflammation and peripheral organ dysfunction are closely linked to disease progression. Notably, the bladder and kidney have emerged as peripheral organs that respond sensitively to neuroinflammation and systemic inflammatory signaling. In this review, we synthesize current evidence supporting a bladder-kidney-brain axis in AD, with emphasis on inflammatory pathways that connect central neurodegeneration with peripheral organ responses. We categorize biomarkers reflecting functional alterations, cellular stress responses, and tissue injury in the bladder and kidney, highlighting mediators reported in both organs. Importantly, many of these biomarkers are measurable in serum and urine, offering accessible peripheral readouts of AD-associated systemic pathology. This integrated framework underscores the biological relevance of urological organs in AD progression and provides a conceptual basis for identifying peripheral signatures associated with early disease-related changes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.